I nfectIons in patients with illnesses of the CNS who are admitted to an intensive care unit (ICU) can be difficult to recognize, due to the prior use of antibiotics and/or steroids 6 and to the lack of support from clinical criteria after craniotomies.
environments increases the risk of patient mortality to approximately 35% 13 and is associated with neurological sequelae, including mild cognitive deterioration to serious neurological deficits or vegetative states. 51 Consequently, early diagnosis is important for coordinating medical and pharmacological treatment.
NM presents in patients with a history of neurosurgical procedures, such as craniotomies or ventriculostomies, and in whom invasive neuromonitoring techniques have been used, among other procedures. 49 It is likely that infections originate in the surgical procedures themselves, either via direct inoculation of residual bacteria from the patients' skin or via adjacent dissemination of other infected tissues, and occasionally via direct exposure from the hands of the surgical team. 14, 49 Diagnosing NM in neurosurgical patients is complicated because it is common for them to have meningeal symptoms such as neck rigidity, fever, and headaches. 6 Similarly, most of them have received antibiotics (82%-100%) or steroids (50%-85%) before receiving a lumbar puncture to obtain a sample of CSF. 38, 39 Therefore, the standard test of the CSF leukocyte counts, glucose, and protein concentration is not diagnostically optimal. Additionally, CSF cultures are negative in as many as 70% of cases. 3 Consequently, additional CSF parameters are required for a proper diagnosis. 26, 39 CSF lactate levels in neurosurgical patients have been used to clarify diagnoses. 10, 20, 27, 32, 46, 53 Leib et al. used 4 mmol/L or more as the cutoff value to identify patients presenting with bacterial meningitis after neurosurgery, with a sensitivity of 88% and specificity of 98%. 26 Later studies have used cutoff values between 1.9 and 5.4 mmol/L, 10, 20, 27, 32, 46, 53 achieving sensitivities between 86% and 97% and specificities between 78% and 100%. However, some acute neurological diseases also increase lactate levels, including cerebrovascular disease, 5, 18 convulsions, 42 brain injury, 11 and hypoglycemic coma.
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The stated difficulties in the diagnosis of NM have spurred the need to find other markers of infection, including C-reactive protein (CRP), 19 inflammatory cytokines, 28 and prolactin. 2, 31 A number of infection risk factors (RFs) have also been identified, such as CSF leak, 39 tumor removal (especially gliomas), 16 transsphenoidal surgery, 48 repeated surgical procedures, 36 the duration of external ventricular drainage, 14 and the diagnosis leading to hospital admission, such as traumatic brain injury (TBI) or aneurysmal subarachnoid hemorrhage (aSAH), 13 ,17 among others.
The diagnostic approach for NM therefore presents a challenge to neurocritical patients, and the decision regarding whether to start antibiotic treatment is a constant concern for clinicians, as these medications are associated with complications such as toxicity or high cost. 16, 38, 39 The clinical prediction rules have been used in communityacquired meningitis and have been of great assistance in clarifying and optimizing the management of this illness. 4, 43 To the best of our knowledge, there are not yet clinical prediction rules for the diagnosis of NM. Consequently, the objective of this study was to develop a diagnostic prediction rule for NM using a combination of clinical, laboratory, and CSF-based variables, as well as RFs for neuroinfection in patients from 4 ICUs in Medellín, Colombia.
Methods

Study Design
A cross-sectional study was performed on patients suspected of NM and hospitalized in an ICU. The study was conducted in 3 multipurpose ICUs from Level-4 hospitals (Clínica Medellín, Hospital Pablo Tobón Uribe, and Clínica Las Américas) and an ICU from a neurology clinic (Neurological Institute of Colombia [Instituto Neurológico de Colombia]) in Medellín, Colombia. The protocol was previously approved by the ethics committee of each institution.
Postneurosurgical patients of both sexes were eligible for this study, provided that they were 13 years of age or older, were admitted to 1 of the above ICUs between 2010 and 2013, had a sample of CSF taken for lactate measurement during their hospital admission, and were subjected to laboratory tests, including a blood panel and CRP, all as diagnostic tests for suspicion of neuroinfection. Patients were excluded if they had a ventriculoperitoneal shunt (VPS).
Patients were suspected of having NM if they had a history of neurosurgical procedures, such as craniotomies or ventriculostomies, within the previous 40 days and/or had undergone invasive neuromonitoring techniques. Patients were also considered if they had a clinical presentation of fever, defined as an axillary temperature greater than 38°C, and/or an increase in acute-phase reactants, defined as an increase in leukocytes and/or high-sensitivity CRP. Patients were not considered suspicious for NM if they had a permanent VPS.
Outcome
The diagnosis categories proposed by Leib et al. were used: 26 1) confirmed meningitis: positive CSF culture and a CSF leukocyte count > 250 cells/L; 2) probable meningitis: CSF leukocyte count > 1000 cells/L with > 50% neutrophils or count > 250 cells/L with > 50% neutrophils (if the patient had a history of steroid and/or antibiotic use at the time of the lumbar puncture); and 3) rejected meningitis: negative CNS culture and CSF leukocyte count < 250 cells/L with < 50% neutrophils.
To improve the diagnostic accuracy during the analysis, the patients were classified into 2 groups: those with confirmed and probable NM, and those with NM ruled out. This classification was considered because CSF or blood cultures usually are positive in a minority of patients and also because patients with possible or presumptive NM usually receive care and focus as if they had confirmed NM. Additionally, there were no significant differences when comparing variables within the confirmed and probable NM patient groups (p > 0.05; Appendix).
Data Collection and Predictors
Forty variables were initially considered (Table 1 ). According to hospital records from prior years, the total number of patients with confirmed/probable NM was calculated to be approximately 150. With this value, up to 15 independent variables might be included in the multivari-ate model, following the guide of 10 outcomes for each predictor. 35 Missing values were replaced by the median value of the corresponding group (confirmed/probable NM or NM ruled out).
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The variables were retrospectively obtained from the clinical records of the participating institutions. Six previously trained investigators formed part of the group that collected the patient data: 1) Instituto Neurológico de Colombia: an intensivist studying for a Master's degree and 2 neurology residents; 2) Clínica Las Américas: an intensive care medical student; 3) Hospital Pablo Tobón Uribe: an intensive care medical student; and 4) Clínica Medellín: an epidemiologist intensivist). The techniques for processing the tests were similar among the participating institutions. The data gathering was standardized, using an operations manual and storage in a structured database developed in a Java platform; the database was later exported 
Statistical Methods
All of the continuous variables were transformed into dichotomous variables so that the generated model could be simple and more useful in clinical practice. The same cutoff points defined by Leib et al. were used:
26 CSF lactate with a cutoff of ≥ 4 mmol/L, CSF/blood glucose ratio ≤ 0.4, CSF leukocytes ≥ 250 cells, and CSF neutrophils ≥ 50%. For the other continuous variables, the best cutoff was determined using the receiver operating characteristic (ROC) curve (resulting in a cutoff point for maximum sensitivity and specificity) for CRP, age, and blood loss in milliliters, as well as the locally weighted scatterplot smoothing algorithm (value corresponding to the change in the behavior of the monotonically increasing or decreasing function) for surgery time.
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The median and the interquartile range (IQR) were used for the descriptions of the variables in the confirmed/probable NM and NM ruled-out groups. Comparisons between the 2 groups of categorical variables were performed with either a c 2 test or Fisher's exact test, while the quantitative variables used the Student t-test or Mann-Whitney U-test.
Multivariate analysis was performed using logistic regression with the presence or absence of NM acting as the dependent variable. Potential predictors with a p value < 0.20 in the bivariate analysis, among those 40 initially considered, were tested in the multivariate model, taking into account the clinical criteria. This procedure was verified with an automatic (backward stepwise) and manual algorithm, using the same criteria of statistical significance. The results of the final multivariate model are presented as odds ratios (ORs) with their respective confidence intervals (CIs) and p values. The absence of multicollinearity was verified by a variance inflation factor below 10 and interaction terms were not considered.
After determining the best model based on discrimination (area under the ROC [AUROC] curve) and calibration (Hosmer-Lemeshow goodness-of-fit test), scores for the prediction rule were defined with the b coefficient for each significant variable. 25, 52 The coefficient was first multiplied by 10 and then divided by the smallest whole number among all the variables. Finally, each variable was rounded to the closest whole number while conserving proportionality.
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With the variables selected for the best model, the probability of NM was derived from a logistic model with relative weights (regression coefficients) from each variable:
The sum of the scores obtained based on the presence or absence of the respective variables in each patient determined the probability of NM.
Sensitivity Analysis
Internal validation was performed using bootstrapping with 200 repetitions. 44 In addition, a new analysis was performed only for confirmed NM with a positive CSF culture, only for probable NM excluding cases with a positive CSF culture, and without variable imputation.
Model Performance
The accuracy of each of the potential models was verified and compared in terms of calibration and discrimina- tion. Calibration was evaluated using the Hosmer-Lemeshow goodness-of-fit test, where p values > 0.05 indicated no significant difference between the observed and predicted outcomes. Discrimination was evaluated using the AUROC curve, where a value close to 1 indicates a greater probability that the outcome was predicted correctly in randomly chosen pairs of patients.
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Results
Participants
The clinical histories of 731 patients admitted to the 4 ICUs between 2010 and 2013 were reviewed, extracting data for 320 patients who met the eligibility criteria. A complete analysis was performed on all participants (Fig.  1 ). There were 30 missing values in 4 different variables from 21 patients (1 blood panel, 7 CRPs, 12 blood losses, and 10 surgical times), corresponding to 3.6% of the data from the eligible patients.
Data Description
A total of 154 patients (48.1%) with confirmed/probable NM and 166 (51.9%) with NM ruled out were admitted to the study ( Table 2 ). The median age of the confirmed/ probable NM group was 54 years (IQR 43-62 years), and 49 years (IQR 33-61 years) for the group with NM ruled out (p = 0.033; Table 3 ).
The diagnoses that showed a statistically significant difference between the confirmed/probable NM group and the NM ruled-out group were aSAH (31.8% vs 12.7%, p = 0.00) and TBI (24% vs 37.3%, p = 0.01). Among the surgical procedures, transsphenoidal tumor resection and placement of a ventricular shunt were significantly different between the study groups (p = 0.073 and 0.001, respectively). Of the injury characteristics, only ventricular hemorrhage showed a higher percentage in the confirmed/ probable group (33.1% vs 16.9%, p = 0.001). Among the neuroinfection RFs, CSF leak, daily CSF draining via an external ventricular drain (EVD), surgical duration, and bleeding during surgery differed between the patients of each group (p < 0.20). Of the NM symptoms, only neurological deterioration differed between the groups: 72.1% for confirmed/probable NM versus 45.2% for NM ruled out (p < 0.05). Of the parameters from the laboratory serum analysis, only CRP tests differed between the groups (p = 0.07). The parameters studied in CSF-glucose, leukocytes, neutrophils, proteins, and lactate-showed significant differences between the confirmed/probable NM group and the NM ruled-out group (Tables 2 and 3) . variables that met both the clinical and statistical criteria of p ≤ 0.20. Despite meeting the statistical criteria, neither a history of transsphenoidal surgery nor CSF proteins were included, the former because of an insufficient number of patients and the latter because of a lack of consistent results in previous studies.
In both the manual selection and the stepwise backward logistic regression analysis for the final model, the 6 dichotomized variables that best predicted outcome were: Table 5 ).
The final model showed good calibration using the Hosmer-Lemeshow goodness-of-fit test (c 2 = 4.52, degrees of According to the b coefficients for each variable, values were assigned as follows: 1 for aSAH diagnosis, 1 for CRP ≥ 6 mg/dl, 1 for CSF/blood ratio ≤ 0.4 mmol/L, 1.5 for CSF leak, 1.5 for CSF PMN neutrophils ≥ 50%, and 4 for CSF lactate ≥ 4 mmol/L, for a total score of 10 points (Table 6 ). Table 7 shows the proportion of diagnoses according to the score values.
The sensitivity analysis revealed that, in comparing patients with confirmed NM to those with NM ruled-out, the model discrimination had an AUROC of 0.795 and continued with sufficient calibration under the HosmerLemeshow test (p = 0.92). When comparing the patients with probable NM, the sensitivity analysis yielded model discrimination with an AUROC of 0.94 and sufficient calibration under the Hosmer-Lemeshow test (p = 0.82). Model parameters were not affected by excluding cases in which the variables had missing data (see Appendix). On performing bootstrapping with 200 repetitions for internal validation, no significant differences were found regarding the model, the variables, or their regression coefficients. 
Discussion
In this study we developed a diagnostic prediction rule for postsurgical meningitis with a total score of 10 points, according to simple clinical and laboratory variables routinely used in ICU patients with suspected neuroinfection. A score greater than 6 points suggests a high probability of neuroinfection, carrying a recommendation of treating the patient with antibiotics. This prediction rule therefore improves the diagnostic accuracy in patients with suspicion of NM.
This rule has a sensitivity of 81.2% (95% CI 74.7%-87.7%), a specificity of 95.8% (95% CI 92.4%-99.1%), a positive predictive value (PPV) of 94.7% (95% CI 90.5%-98.9%), and a negative predictive value (NPV) of 84.6% (95% CI 79.1%-90%), with an AUROC of 0.94.
Our findings corroborate that a diagnostic prediction rule for patients with NM should have clinical variables and laboratory and CSF tests that are already reported in the literature. Until now, measuring CSF lactate 20, 26, 27, 32, 53 was the primary method of diagnosing NM; however, this marker is not sufficient for accurate diagnosis. 10, 20, 26, 27, 46 Our diagnostic prediction rule adds additional clinical and laboratory markers, such as the glucose ratio and CRP, which could facilitate delivering a more accurate NM diagnosis.
Prognostic Factors in Our Model
Diagnosis of aSAH aSAH is a frequent cause of ICU admittance, and fever presenting in this illness is associated with poor clinical outcome. 40 Generally, elevated degrees of aSAH and intraventricular bleeding are associated with fever and poor prognosis. 15 In a study by Commichau et al., aSAH was the only diagnostic category associated with infectious (OR 2.96, 95% CI 1.17-7.45) or noninfectious (OR 2.78, 95% CI 1.02-7.60) fever, most likely due to a need for invasive devices such as EVDs, hypothalamic dysfunction, and thermoregulatory alterations. 9 The study by Frontera et al. showed that NM is one of the most prevalent nosocomial infections in patients with aSAH (28.5%), which worsens the outcome of patients compared with noninfected patients (mortality rate 42% vs 25%); thus, it is important to prevent and manage this condition. 17 Our patients have elevated degrees of aSAH with ventricular hemorrhage requiring different procedures such as an EVD placement, which are factors associated with ventriculitis/meningitis.
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CRP ≥ 6 mg/dl
CRP is an acute-phase reactant primarily synthesized in the liver; serum levels of the protein are usually elevated up to 6 hours after an inflammatory injury. Levels of CRP have been evaluated in patients suspected of meningitis in a number of studies, 41, 50 including a meta-analysis.
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The study by Choi and Choi evaluated the performance of procalcitonin and inflammatory markers as diagnostic characteristics for NM. Using a cutoff point for CRP ≥ 2.58 mg/dl, these investigators demonstrated a sensitivity of 75%, a specificity of 53.5%, a positive predictive value (PPV) of 31%, a negative predictive value (NPV) of 88% and an AUROC of 0.65. 8 In our study we defined a cutoff point for CRP of ≥ 6 mg/dl based on an AUROC because, when our study began, no published works had used cutoff points for this criterion.
CSF Lactate ≥ 4 mmol/L
Several studies describe the use of CSF lactate for use in the diagnosis of neurosurgical patients. 10, 20, 26, 27, 32, 46, 53 The cutoff point of 4 mmol/L used in the present investigation was the same as that used in Leib et al.'s pioneering investigation into neuroinfection in postoperative patients.
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When used in the model, this cutoff point produced adequate efficiency; alone, CSF lactate ≥ 4 mmol/L was responsible for a sensitivity of 71%, a specificity of 97%, a PPV of 96%, and an NPV of 78%.
CSF/Blood Glucose Ratio ≤ 0.4 mmol/L Leib et al.'s study also evaluated a glucose ratio of 0.4 or less in neuroinfection, and although it had a poorer performance (sensitivity 77%, specificity 87%), they concluded that it nevertheless aided in an NM diagnosis. 26 This variable is likely found in our model because a link between hypoglycorrhachia and elevated lactate is common in patients with neuroinfection. 
Applicability and Limitations
Clinical prediction and decision rules have been used for community-acquired meningitis to clarify and optimize the medical treatment. 4, 34 No studies have been published describing the creation of clinical prediction rules for NM. To evaluate the performance of this diagnostic model it is necessary to validate it prospectively in an independent sample, after which it could be used in other environments with the goal of optimizing the diagnosis of NM. 37, 47 To control the information and selection biases, the principal investigator performed an audit on each of the records to minimize errors in data collection; whenever extreme values or nonconcordant data were found, the clinical histories were reviewed again at each institution. A partial verification bias may be associated with the low frequency of confirmed NM, which is the perfect gold standard for the disease. For this study, the patients with confirmed/probable NM were treated as a single group to improve the diagnostic precision in the analysis. Ideally, the model would have been fitted with confirmed NM as the outcome but the number of patients who qualified was too low, which would have limited the possibility of testing all the significant predictors in the multivariate analysis. For probable NM, we resorted to the diagnosis assigned by attending physicians at the ICU and by the infections committees that, based on the specific characteristics observed in the patients and on the suspicion of neuroinfection, decided to treat them with antibiotics, independent of whether the CSF culture turned up negative. Thus, many of the variables considered in the prediction rule probably were also considered part of this ancillary gold standard. Finally, the rates of meningitis are relatively high in our study population, which reflects that the inclusion criteria were broad enough. This is a very important point, as the usefulness of a diagnosis test or a prediction rule is related to the previous probability of disease. Our broad clinical criteria are a consequence of the lack of an adequate gold standard for diagnosis. Although clinical and laboratory variables are relatively common, the yield of cultures is extremely low and this is exactly the justification for our research: to provide a simple and practical clinical tool for the physician.
Conclusions
A score constructed using the variables of aSAH diagnosis, CRP ≥ 6 mg/dl, CSF/blood glucose ratio ≤ 0.4 mmol/L, the existence of a CSF leak, CSF PMN neutrophils ≥ 50%, and CSF lactate ≥ 4 mmol/L, comprises a diagnostic prediction rule for NM with good calibration (Hosmer-Lemeshow test, c 2 = 4.52, p = 0.71) and excellent discrimination (AUROC = 0.94). This model must be externally validated with independent data as an ideal starting point for optimal diagnosis of postsurgical meningitis. 
